Rankings
▼
Calendar
AMRX Q4 2016 Earnings — Amneal Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
AMRX
Amneal Pharmaceuticals, Inc.
$4B
Q4 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$299M
Gross Profit
$177M
59.2% margin
Operating Income
$92M
30.9% margin
Net Income
$54M
18.1% margin
EPS (Diluted)
$0.29
Cash Flow
Operating Cash Flow
$36M
Free Cash Flow
$5M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$1.2B
Total Liabilities
$1.4B
Stockholders' Equity
-$185M
Cash & Equivalents
$27M
← FY 2016
All Quarters
Q1 2017 →
